3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Cystitis, Interstitial
1
Interventions
Specimen Handling
624
pembrolizumab
603
Magnetic Resonance Spectroscopy
550
Carboplatin
444
Cisplatin
394
Cyclophosphamide
392
Biopsy
368
Paclitaxel
320
Nivolumab
320
Gemcitabine
313
Radiotherapy
279
Bevacizumab
242
Dexamethasone
220
fludarabine
210
Docetaxel
197
durvalumab
192
Oxaliplatin
184
venetoclax
182
atezolizumab
182
Fluorouracil
174
Rituximab
172
Pemetrexed
171
Capecitabine
167
Doxorubicin
164
Radiation
162
Radiosurgery
156
Ipilimumab
143
Etoposide
142
Leucovorin
140
Lenalidomide
136
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Chondroitin Sulfates
×
90 days
×
Clear all
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled